ArticleOncoTargets and therapy2022

Hepatoid Adenocarcinoma of the Lung: Beyond a Shadow of Doubt and Risk of High Mortality [Letter].

Syeda Sakina Zehra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.